"The things they say researchers will focus on -- autism diagnosis trends over time, health outcomes from specific medical and behavioral intervention, access to care and disparities by ...

Major healthcare data analytics firm Episource had a cybersecurity incident exposing 5 million patients' medical records and personal information in recent breach.

MediScan AI, a Seattle startup using artificial intelligence to help medical professionals evaluate patient records, raised $1.4 million in funding, the company announced Friday.

A large language model (LLM) deployed to make treatment recommendations can be tripped up by nonclinical information in patient messages, like typos, extra white space, missing gender markers, or ...

Albany Medical Center has recorded five incidents of surgical objects mistakenly left in patients over the last five years, according to Albany Med Health System spokesman Matt Markham.

"Harte Hanks' licensing rights to our flagship health database reflects their vision and leadership in data-driven marketing," said Eric Nelson, President & Managing Partner of ADS Data Direct.

Clinical outcomes of patients with primary refractory metastatic renal cell carcinoma receiving second-line (2L) therapies: An International Metastatic Database Consortium (IMDC) study.

Medical errors are still harming patients. AI could help change that. Medication mistakes — in which the wrong drug or the wrong dose is given to a patient — are among the most common errors ...

After Amazon One Medical patient Phillip Tong died, nine clinic employees viewed his medical records in alleged violation of California law, court documents say.

TOH is using Microsoft’s DAX Copilot to capture physician-patient conversations and generate draft clinical notes in real time.

Several lines of treatment can be used sequentially in patients with metastatic colorectal cancer. We investigated the evolution of patient/tumor characteristics and their prognostic impact across ...

Flatiron will use Massive Bio’s database to identify cancer patients that live close to clinical trial sites but aren’t participating in a trial yet.